40 USD
+0.09 (+0.23%)
40 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to AZTA. AZTA was compared to 57 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for AZTA as it has an excellent financial health rating, but there are worries on the profitability. AZTA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- AZTA had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -2.71%, AZTA perfoms like the industry average, outperforming 54.39% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -3.23%, AZTA is in line with its industry, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AZTA has a Gross Margin (45.52%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of AZTA has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AZTA has more shares outstanding
- Compared to 5 years ago, AZTA has less shares outstanding
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- AZTA has an Altman-Z score of 4.80. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
- AZTA has a Altman-Z score of 4.80. This is in the better half of the industry: AZTA outperforms 77.19% of its industry peers.
- AZTA has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
- The Debt to FCF ratio of AZTA (0.04) is better than 92.98% of its industry peers.
- A Debt/Equity ratio of 0.00 indicates that AZTA is not too dependend on debt financing.
- AZTA has a Debt to Equity ratio of 0.00. This is in the better half of the industry: AZTA outperforms 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 4.8 |
ROIC/WACCN/A
WACC11.06%
2.3 Liquidity
- A Current Ratio of 2.98 indicates that AZTA has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.98, AZTA is in line with its industry, outperforming 54.39% of the companies in the same industry.
- AZTA has a Quick Ratio of 2.66. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- With a Quick ratio value of 2.66, AZTA perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 29.27% over the past year.
- The earnings per share for AZTA have been decreasing by -16.04% on average. This is quite bad
- Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -9.52% in the last year.
- The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
3.2 Future
- AZTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.49% yearly.
- Based on estimates for the next years, AZTA will show a small growth in Revenue. The Revenue will grow by 5.37% on average per year.
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 75.47 indicates a quite expensive valuation of AZTA.
- The rest of the industry has a similar Price/Earnings ratio as AZTA.
- AZTA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.38.
- With a Price/Forward Earnings ratio of 50.07, AZTA can be considered very expensive at the moment.
- AZTA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 61.40% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. AZTA is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.47 | ||
| Fwd PE | 50.07 |
4.2 Price Multiples
- AZTA's Enterprise Value to EBITDA is on the same level as the industry average.
- Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than 63.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.87 | ||
| EV/EBITDA | 36.27 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- AZTA's earnings are expected to grow with 34.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.49
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y34.08%
5. Dividend
5.1 Amount
- AZTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
40
+0.09 (+0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-21 2025-11-21/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners111.91%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change11.23%
Market Cap1.83B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Analysts75.71
Price Target40.22 (0.55%)
Short Float %9.1%
Short Ratio6.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.43%
Min EPS beat(2)8.65%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)13.04%
Min EPS beat(4)-29.97%
Max EPS beat(4)37.26%
EPS beat(8)7
Avg EPS beat(8)70.99%
EPS beat(12)10
Avg EPS beat(12)146.49%
EPS beat(16)14
Avg EPS beat(16)123.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.95%
PT rev (1m)2.22%
PT rev (3m)25.45%
EPS NQ rev (1m)1.29%
EPS NQ rev (3m)-17.81%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.47 | ||
| Fwd PE | 50.07 | ||
| P/S | 3.09 | ||
| P/FCF | 47.87 | ||
| P/OCF | 25.41 | ||
| P/B | 1.06 | ||
| P/tB | 1.99 | ||
| EV/EBITDA | 36.27 |
EPS(TTM)0.53
EY1.33%
EPS(NY)0.8
Fwd EY2%
FCF(TTM)0.84
FCFY2.09%
OCF(TTM)1.57
OCFY3.93%
SpS12.95
BVpS37.66
TBVpS20.12
PEG (NY)1.49
PEG (5Y)N/A
Graham Number21.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% | ||
| FCFM | 6.45% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 55.31% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 182.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z | 4.8 |
F-Score5
WACC11.06%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%
EBIT growth 1Y70.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year516.37%
EBIT Next 3Y105.29%
EBIT Next 5YN/A
FCF growth 1Y210.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.11%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 3 / 10 to AZENTA INC (AZTA). This can be considered as Overvalued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 7 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.